Scaini Giselli, Maggi Débora D, De-Nês Bruna T, Gonçalves Cinara L, Ferreira Gabriela K, Teodorak Brena P, Bez Gisele D, Ferreira Gustavo C, Schuck Patricia F, Quevedo João, Streck Emilio L
Laboratório de Fisiopatologia Experimental, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil.
Programa de Pós-graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, Tubarão, SC, Brazil.
Acta Neuropsychiatr. 2011 Jun;23(3):112-8. doi: 10.1111/j.1601-5215.2011.00548.x.
Depressive disorders, including major depression, are serious and disabling for affected patients. Although the neurobiological understanding of major depressive disorder focuses mainly on the monoamine hypothesis, the exact pathophysiology of depression is not fully understood.
Animals received daily intra-peritoneal injections of paroxetine (10 mg/kg), nortriptyline (15 mg/kg) or venlafaxine (10 mg/kg) in 1.0 ml/kg volume for 15 days. Twelve hours after the last injection, the rats were killed by decapitation, where the brain was removed and homogenised. The activities of mitochondrial respiratory chain complexes in different brain structures were measured.
We first verified that chronic administration of paroxetine increased complex I activity in prefrontal cortex, hippocampus, striatum and cerebral cortex. In addition, complex II activity was increased by the same drug in hippocampus, striatum and cerebral cortex and complex IV activity in prefrontal cortex. Furthermore, chronic administration of nortriptyline increased complex II activity in hippocampus and striatum and complex IV activity in prefrontal cortex, striatum and cerebral cortex. Finally, chronic administration of venlafaxine increased complex II activity in hippocampus, striatum and cerebral cortex and complex IV activity in prefrontal cortex.
On the basis of the present findings, it is tempting to speculate that an increase in brain energy metabolism by the antidepressant paroxetine, nortriptyline and venlafaxine could play a role in the mechanism of action of these drugs. These data corroborate with other studies suggesting that some antidepressants modulate brain energy metabolism.
包括重度抑郁症在内的抑郁障碍对受影响的患者来说严重且致残。尽管对重度抑郁症的神经生物学理解主要集中在单胺假说上,但抑郁症的确切病理生理学尚未完全明确。
动物每天腹腔注射帕罗西汀(10毫克/千克)、去甲替林(15毫克/千克)或文拉法辛(10毫克/千克),剂量为1.0毫升/千克,持续15天。最后一次注射12小时后,通过断头处死大鼠,取出大脑并匀浆。测量不同脑区线粒体呼吸链复合物的活性。
我们首先证实,长期给予帕罗西汀可增加前额叶皮质、海马体、纹状体和大脑皮质中复合物I的活性。此外,该药物还可增加海马体、纹状体和大脑皮质中复合物II的活性以及前额叶皮质中复合物IV的活性。此外,长期给予去甲替林可增加海马体和纹状体中复合物II的活性以及前额叶皮质、纹状体和大脑皮质中复合物IV的活性。最后,长期给予文拉法辛可增加海马体、纹状体和大脑皮质中复合物II的活性以及前额叶皮质中复合物IV的活性。
基于目前的研究结果,很容易推测抗抑郁药帕罗西汀、去甲替林和文拉法辛增加脑能量代谢可能在这些药物的作用机制中发挥作用。这些数据与其他表明一些抗抑郁药可调节脑能量代谢的研究结果一致。